Ruth Braganza

Performance of two commercially available sequence‐based HIV‐1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes

Simon Beddows, S. Galpin, Shamim H. Kazmi et al. · Journal of Medical Virology · 2003 · 47 citations

Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy

John R. Clarke, Ruth Braganza, Asiya Mirza et al. · Journal of Medical Virology · 1999 · 44 citations

Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors

Steve Price, Walter Bordogna, Ruth Braganza et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 33 citations · Full text

Medicinal Chemistry, Biochemistry, Potent Histone Deacetylase +12

Discordant Outcomes following Failure of Antiretroviral Therapy Are Associated with Substantial Differences in Human Immunodeficiency Virus-Specific Cellular Immunity

David A. Price, G Scullard, Annette Oxenius et al. · Journal of Virology · 2003 · 31 citations · Full text

Immunology, Plasma Virus, Immunotherapy +16

Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients

John R. Clarke, S. Galpin, Ruth Braganza et al. · Journal of Medical Virology · 2000 · 29 citations

Immunology, Genetic Epidemiology, Diverse Population +18